Primary failure of measles vaccine in a ten-year-old boy
Toft Kristensen, M.A.
Ugeskrift for Laeger 175(9): 567-568
2013
ISSN/ISBN: 1603-6824 PMID: 23608005 Document Number: 664357
79% of all four-year-old Danish children are vaccinated twice for measles, mumps and rubella (MMR). Administration of the second MMR dose is recommended in order to prevent primary vaccine failure, which occurs in 5%. In 2011 the largest outbreak of measles for 15 years took place in Denmark and this is a case report of measles in a ten-year-old vaccinated boy. He had received a single dose of MMR vaccine at the recommended age of 17 months. To prevent larger outbreaks of measles, a larger percentage of Danish children must receive the recommended two doses of vaccine for MMR.
Document emailed within 1 workday
Related Documents
Fowlkes, A.; Witte, D.; Beeler, J.; Audet, S.; Garcia, P.; Curns, A.; Yang, C.; Fudzulani, R.; Broadhead, R.; Bellini, W.J.; Cutts, F.; Helfand, R.F. 2011: Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi Journal of Infectious Diseases 204(Suppl 1): S149-S157Tikhonova, N.T.; Khrometskaia, T.M.; Livanova, L.V.; Poliakova, T.A.; Azarova, S.A. 1978: Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles Voprosy Virusologii 3: 322-327
Kent, S.J.; Greenberg, P.D.; Hoffman, M.C.; Akridge, R.E.; McElrath, M.J. 1997: Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure Journal of Immunology 158(2): 807-815
Trier, H.; Rønne, T. 1992: Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella Ugeskrift for Laeger 154(29): 2008-2013
Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771
Makino, S.; Sasaki, K.; Nakamura, N.; Nakagawa, M.; Nakajima, S. 1974: Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine Kitasato Archives of Experimental Medicine 47(1-2): 13-21
Rotily, M.; Guagliardo, V.; Fontaine, D.; Garros, B.; Mayer, C.; Arrighi, J.; Woronoff, A.S.; Ledesert, B.; Lepec, R.; Chabaud, F.; Janvrin, M.P.; Baudier, F. 2001: Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors Revue d'Epidemiologie et de Sante Publique 49(4): 331-341
Techasena, W.; Sriprasert, P.; Pattamadilok, S.; Wongwacharapipoon, P. 2007: Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months Journal of the Medical Association of Thailand 90(1): 106-112
Modlin, J.F.; Jabbour, J.T.; Witte, J.J.; Halsey, N.A. 1977: Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis Pediatrics 59(4): 505-512
Kanbur, N.Oksüz.; Derman, O.; Kutluk, T. 2005: Measles seroprevalence of an adolescent population vaccinated with a single dose of measles vaccine before their first birthday International Journal of Adolescent Medicine and Health 17(4): 337-341
Li, Q.; Hu, Y.; Qi, X-hua.; Lou, L-qiao.; Luo, S-ying.; Tang, X-wen.; Chen, E-fu. 2013: Analysis on coverage rate of primary immunization of measles vaccine among migrant children in Yiwu, Zhejiang province from 2007 to 2010 Zhonghua yu fang yi xue za zhi 47(6): 504-509
Markowitz, L.E.; Nieburg, P. 1991: The burden of acute respiratory infection due to measles in developing countries and the potential impact of measles vaccine Reviews of Infectious Diseases 13(Suppl): S555-S561
Hutchins, S.S.; Escolan, J.; Markowitz, L.E.; Hawkins, C.; Kimbler, A.; Morgan, R.A.; Preblud, S.R.; Orenstein, W.A. 1989: Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine Pediatrics 83(3): 369-374
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Bahl, R.; Kumar, R.; Bhandari, N.; Kant, S.; Srivastava, R.; Bhan, M.K. 1999: Vitamin a administered with measles vaccine to nine-month-old infants does not reduce vaccine immunogenicity Journal of Nutrition 129(8): 1569-1573
Trotter, A.C.; Stone, B.D.; Laszlo, D.J.; Georgitis, J.W. 1994: Measles, mumps, rubella vaccine administration in egg-sensitive children: systemic reactions during vaccine desensitization Annals of Allergy 72(1): 25-28
Domorázková, E.; Drevo, M.; Burian, V.; Burianová-Vysoká, B.; Janotová, J.; Kratochvílová, M.; Kríz, J.; Vodicková, M.; Kyselová, M. 1973: Use of live measles vaccine in the 3d injection of basic DTPA vaccine (Diphtheria, Tetanus, Pertussia Antitoxin) Ceskoslovenska Pediatrie 28(3): 129-130
Stück, B.; Stehr, K.; Bock, H.L. 2002: Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age Asian Pacific Journal of Allergy and Immunology 20(2): 113-120
Gatchalian, S.; Tabora, C.; Bermal, N.; Leboulleux, D.; Desauziers, E. 2004: Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old American Journal of Tropical Medicine and Hygiene 70(3): 273-277
Sabin, A.B.; Flores Arechiga, A.; Fernández de Castro, J.; Albrecht, P.; Sever, J.L.; Shekarchi, I. 1984: Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response JAMA 251(18): 2363-2371